HEALTHPEAK PROPERTIES INC (DOC) Stock Fundamental Analysis
NYSE:DOC • US42250P1030
17.6139 USD
-0.02 (-0.09%)
Last: Mar 3, 2026, 03:11 PM
Overall DOC gets a fundamental rating of 3 out of 10. We evaluated DOC against 122 industry peers in the Diversified REITs industry. While DOC is still in line with the averages on profitability rating, there are concerns on its financial health. While showing a medium growth rate, DOC is valued expensive at the moment.
1. Profitability
1.1 Basic Checks
- DOC had positive earnings in the past year.
- In the past year DOC had a positive cash flow from operations.
- DOC had positive earnings in each of the past 5 years.
- DOC had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
- Looking at the Return On Assets, with a value of 0.35%, DOC is in line with its industry, outperforming 45.08% of the companies in the same industry.
- With a Return On Equity value of 0.94%, DOC perfoms like the industry average, outperforming 45.90% of the companies in the same industry.
- DOC has a Return On Invested Capital (2.24%) which is comparable to the rest of the industry.
- Measured over the past 3 years, the Average Return On Invested Capital for DOC is in line with the industry average of 3.09%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.35% | ||
| ROE | 0.94% | ||
| ROIC | 2.24% |
ROA(3y)1.17%
ROA(5y)1.99%
ROE(3y)2.87%
ROE(5y)4.76%
ROIC(3y)2.27%
ROIC(5y)2.16%
1.3 Margins
- DOC has a Profit Margin of 2.50%. This is comparable to the rest of the industry: DOC outperforms 44.26% of its industry peers.
- DOC's Profit Margin has declined in the last couple of years.
- DOC's Operating Margin of 19.31% is in line compared to the rest of the industry. DOC outperforms 45.90% of its industry peers.
- DOC's Operating Margin has improved in the last couple of years.
- DOC has a worse Gross Margin (60.00%) than 68.03% of its industry peers.
- DOC's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 19.31% | ||
| PM (TTM) | 2.5% | ||
| GM | 60% |
OM growth 3Y0.32%
OM growth 5Y7.81%
PM growth 3Y-53.06%
PM growth 5Y-36.91%
GM growth 3Y1.1%
GM growth 5Y2.84%
2. Health
2.1 Basic Checks
- DOC has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
- Compared to 1 year ago, DOC has less shares outstanding
- The number of shares outstanding for DOC has been increased compared to 5 years ago.
- Compared to 1 year ago, DOC has a worse debt to assets ratio.
2.2 Solvency
- Based on the Altman-Z score of 0.36, we must say that DOC is in the distress zone and has some risk of bankruptcy.
- The Altman-Z score of DOC (0.36) is comparable to the rest of the industry.
- The Debt to FCF ratio of DOC is 6154.93, which is on the high side as it means it would take DOC, 6154.93 years of fcf income to pay off all of its debts.
- DOC has a Debt to FCF ratio (6154.93) which is in line with its industry peers.
- DOC has a Debt/Equity ratio of 1.27. This is a high value indicating a heavy dependency on external financing.
- DOC's Debt to Equity ratio of 1.27 is in line compared to the rest of the industry. DOC outperforms 48.36% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.27 | ||
| Debt/FCF | 6154.93 | ||
| Altman-Z | 0.36 |
ROIC/WACC0.38
WACC5.86%
2.3 Liquidity
- A Current Ratio of 0.48 indicates that DOC may have some problems paying its short term obligations.
- The Current ratio of DOC (0.48) is worse than 76.23% of its industry peers.
- A Quick Ratio of 0.48 indicates that DOC may have some problems paying its short term obligations.
- Looking at the Quick ratio, with a value of 0.48, DOC is doing worse than 76.23% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.48 | ||
| Quick Ratio | 0.48 |
3. Growth
3.1 Past
- The earnings per share for DOC have decreased by 0.00% in the last year.
- The earnings per share for DOC have been decreasing by -16.06% on average. This is quite bad
- The Revenue has been growing slightly by 4.52% in the past year.
- DOC shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 11.40% yearly.
EPS 1Y (TTM)0%
EPS 3Y-27.44%
EPS 5Y-16.06%
EPS Q2Q%1500%
Revenue 1Y (TTM)4.52%
Revenue growth 3Y11.05%
Revenue growth 5Y11.4%
Sales Q2Q%3.07%
3.2 Future
- DOC is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 0.77% yearly.
- Based on estimates for the next years, DOC will show a small growth in Revenue. The Revenue will grow by 5.62% on average per year.
EPS Next Y-24.56%
EPS Next 2Y-8.84%
EPS Next 3Y0.81%
EPS Next 5Y0.77%
Revenue Next Year1.65%
Revenue Next 2Y2.83%
Revenue Next 3Y3.92%
Revenue Next 5Y5.62%
3.3 Evolution
- When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
- The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
- DOC is valuated quite expensively with a Price/Earnings ratio of 50.33.
- The rest of the industry has a similar Price/Earnings ratio as DOC.
- When comparing the Price/Earnings ratio of DOC to the average of the S&P500 Index (27.13), we can say DOC is valued expensively.
- Based on the Price/Forward Earnings ratio of 66.71, the valuation of DOC can be described as expensive.
- The rest of the industry has a similar Price/Forward Earnings ratio as DOC.
- DOC is valuated expensively when we compare the Price/Forward Earnings ratio to 28.11, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 50.33 | ||
| Fwd PE | 66.71 |
4.2 Price Multiples
- Based on the Enterprise Value to EBITDA ratio, DOC is valued a bit cheaper than 66.39% of the companies in the same industry.
- DOC's Price/Free Cash Flow is on the same level as the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 7651.46 | ||
| EV/EBITDA | 13.49 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-8.84%
EPS Next 3Y0.81%
5. Dividend
5.1 Amount
- DOC has a Yearly Dividend Yield of 6.97%, which is a nice return.
- DOC's Dividend Yield is a higher than the industry average which is at 7.15.
- Compared to an average S&P500 Dividend Yield of 1.82, DOC pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 6.97% |
5.2 History
- The dividend of DOC decreases each year by -4.20%.
- DOC has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)-4.2%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
- DOC pays out 1204.15% of its income as dividend. This is not a sustainable payout ratio.
DP1204.15%
EPS Next 2Y-8.84%
EPS Next 3Y0.81%
NYSE:DOC (3/3/2026, 3:11:09 PM)
17.6139
-0.02 (-0.09%)
Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)02-02 2026-02-02/amc
Earnings (Next)04-22 2026-04-22
Inst Owners97.22%
Inst Owner Change-96.4%
Ins Owners0.22%
Ins Owner Change1.26%
Market Cap12.24B
Revenue(TTM)2.82B
Net Income(TTM)70.51M
Analysts75
Price Target19.83 (12.58%)
Short Float %4.51%
Short Ratio3.26
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 6.97% |
Yearly Dividend1.22
Dividend Growth(5Y)-4.2%
DP1204.15%
Div Incr Years0
Div Non Decr Years0
Ex-Date03-17 2026-03-17 (0.10167)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)108.65%
Min EPS beat(2)37.75%
Max EPS beat(2)179.54%
EPS beat(4)3
Avg EPS beat(4)52.57%
Min EPS beat(4)-19.41%
Max EPS beat(4)179.54%
EPS beat(8)5
Avg EPS beat(8)31.44%
EPS beat(12)8
Avg EPS beat(12)38.23%
EPS beat(16)11
Avg EPS beat(16)56.93%
Revenue beat(2)2
Avg Revenue beat(2)1.99%
Min Revenue beat(2)0.94%
Max Revenue beat(2)3.04%
Revenue beat(4)3
Avg Revenue beat(4)1.41%
Min Revenue beat(4)-0.37%
Max Revenue beat(4)3.04%
Revenue beat(8)7
Avg Revenue beat(8)2.35%
Revenue beat(12)9
Avg Revenue beat(12)-4.49%
Revenue beat(16)11
Avg Revenue beat(16)-3.26%
PT rev (1m)-1.66%
PT rev (3m)-5.05%
EPS NQ rev (1m)-4%
EPS NQ rev (3m)-3.23%
EPS NY rev (1m)0%
EPS NY rev (3m)-3.17%
Revenue NQ rev (1m)-0.14%
Revenue NQ rev (3m)-0.84%
Revenue NY rev (1m)0.28%
Revenue NY rev (3m)-1.15%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 50.33 | ||
| Fwd PE | 66.71 | ||
| P/S | 4.34 | ||
| P/FCF | 7651.46 | ||
| P/OCF | 9.78 | ||
| P/B | 1.63 | ||
| P/tB | 1.81 | ||
| EV/EBITDA | 13.49 |
EPS(TTM)0.35
EY1.99%
EPS(NY)0.26
Fwd EY1.5%
FCF(TTM)0
FCFY0.01%
OCF(TTM)1.8
OCFY10.23%
SpS4.06
BVpS10.79
TBVpS9.75
PEG (NY)N/A
PEG (5Y)N/A
Graham Number9.22
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.35% | ||
| ROE | 0.94% | ||
| ROCE | 2.84% | ||
| ROIC | 2.24% | ||
| ROICexc | 2.3% | ||
| ROICexgc | 2.51% | ||
| OM | 19.31% | ||
| PM (TTM) | 2.5% | ||
| GM | 60% | ||
| FCFM | 0.06% |
ROA(3y)1.17%
ROA(5y)1.99%
ROE(3y)2.87%
ROE(5y)4.76%
ROIC(3y)2.27%
ROIC(5y)2.16%
ROICexc(3y)2.3%
ROICexc(5y)2.18%
ROICexgc(3y)2.51%
ROICexgc(5y)2.37%
ROCE(3y)2.87%
ROCE(5y)2.73%
ROICexgc growth 3Y5.01%
ROICexgc growth 5Y15.76%
ROICexc growth 3Y4.44%
ROICexc growth 5Y15.37%
OM growth 3Y0.32%
OM growth 5Y7.81%
PM growth 3Y-53.06%
PM growth 5Y-36.91%
GM growth 3Y1.1%
GM growth 5Y2.84%
F-Score6
Asset Turnover0.14
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.27 | ||
| Debt/FCF | 6154.93 | ||
| Debt/EBITDA | 5.92 | ||
| Cap/Depr | 118.09% | ||
| Cap/Sales | 44.3% | ||
| Interest Coverage | 2.1 | ||
| Cash Conversion | 78.06% | ||
| Profit Quality | 2.27% | ||
| Current Ratio | 0.48 | ||
| Quick Ratio | 0.48 | ||
| Altman-Z | 0.36 |
F-Score6
WACC5.86%
ROIC/WACC0.38
Cap/Depr(3y)91.62%
Cap/Depr(5y)145.43%
Cap/Sales(3y)33.64%
Cap/Sales(5y)52.36%
Profit Quality(3y)87.79%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)0%
EPS 3Y-27.44%
EPS 5Y-16.06%
EPS Q2Q%1500%
EPS Next Y-24.56%
EPS Next 2Y-8.84%
EPS Next 3Y0.81%
EPS Next 5Y0.77%
Revenue 1Y (TTM)4.52%
Revenue growth 3Y11.05%
Revenue growth 5Y11.4%
Sales Q2Q%3.07%
Revenue Next Year1.65%
Revenue Next 2Y2.83%
Revenue Next 3Y3.92%
Revenue Next 5Y5.62%
EBIT growth 1Y-3.69%
EBIT growth 3Y11.4%
EBIT growth 5Y20.1%
EBIT Next Year254.78%
EBIT Next 3Y58.98%
EBIT Next 5Y35.87%
FCF growth 1Y-99.66%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y16.95%
OCF growth 3Y11.62%
OCF growth 5Y10.54%
HEALTHPEAK PROPERTIES INC / DOC FAQ
Can you provide the ChartMill fundamental rating for HEALTHPEAK PROPERTIES INC?
ChartMill assigns a fundamental rating of 3 / 10 to DOC.
What is the valuation status for DOC stock?
ChartMill assigns a valuation rating of 2 / 10 to HEALTHPEAK PROPERTIES INC (DOC). This can be considered as Overvalued.
Can you provide the profitability details for HEALTHPEAK PROPERTIES INC?
HEALTHPEAK PROPERTIES INC (DOC) has a profitability rating of 5 / 10.
What is the valuation of HEALTHPEAK PROPERTIES INC based on its PE and PB ratios?
The Price/Earnings (PE) ratio for HEALTHPEAK PROPERTIES INC (DOC) is 50.33 and the Price/Book (PB) ratio is 1.63.
How sustainable is the dividend of HEALTHPEAK PROPERTIES INC (DOC) stock?
The dividend rating of HEALTHPEAK PROPERTIES INC (DOC) is 5 / 10 and the dividend payout ratio is 1204.15%.